Search results
Results From The WOW.Com Content Network
Monovalent type A influenza vaccines are generally indicated during the pandemic or the flu for everyone without contraindications. According to the Advisory Committee on Immunization Practices (ACIP) under the Centre for Disease Control and Prevention (CDC), people aged above 10 are recommended to take one dose of H1N1 vaccine while those who are 6 months to 9 years old should be injected ...
The G4 virus, also known as the "G4 swine flu virus" (G4) and "G4 EA H1N1", is a swine influenza virus strain discovered in China. [68] The virus is a variant genotype 4 (G4) Eurasian avian-like (EA) H1N1 virus that mainly affects pigs, but there is some evidence of it infecting people. [ 68 ]
In 2009, a new A/H1N1 influenza virus was discovered to be spreading in North America. In June 2009, the WHO declared the A/H1N1 influenza a pandemic. [76] The National Institute for Health and Care Excellence (NICE), the CDC, the WHO, and the ECDC maintained their recommendation to use oseltamivir. [8] [77]
The vaccine was one of the H1N1 vaccines approved for use by the European Commission in September 2009, upon the recommendations of the European Medicines Agency (EMEA). [4] The vaccine is only approved for use when an H1N1 influenza pandemic has been officially declared by the World Health Organization (WHO) or European Union (EU). [4]
In Russia and China a drug called arbidol is also used as a treatment. Testing of the drug has predominantly occurred in these countries and, although no clinical trials have been published demonstrating this is an effective drug, some data suggest that this could be a useful treatment for influenza. [5] [6]
It was caused by a novel H1N1 strain that was a reassortment of human, swine, and avian influenza viruses. [20] [4] The 2009 pandemic had the effect of replacing prior H1N1 strains in circulation with the novel strain but not any other influenza viruses. Consequently, H1N1, H3N2, and both influenza B virus lineages have been in circulation in ...
On August 17, 2009, Taiwan CDC published the "Clinical Treatment Guideline for Influenza A(H1N1)", which is a result of collaborative work with the Infectious Diseases Society of Taiwan, Taiwan Pediatric Association, Nosocomial Infection Control Society of Taiwan and Taiwan Society of Pulmonary and Critical Care Medicine. [28]
Guidelines, such as those provided by the Centers for Disease Control and Prevention (CDC) during the 2009 flu pandemic caused by the H1N1 virus, recommend, among other things, antiviral treatment regimens, clinical assessment algorithms for coordination of care, and antiviral chemoprophylaxis guidelines for exposed persons. [69]